Effective rates of duty on various categories of P or P medicaments - 029/88 - Central Excise - Tariff

Contents

Effective rates of duty on various categories of P or P medicaments

Notification No. 29/88-C.E.

Dated 1-3-1988

In exercise of the powers conferred by sub-rule (1) of rule 8 of the Central Excise Rules, 1944, the Central Government hereby exempts patent or proprietary medicaments of the description specified in column (2) of the Table hereto annexed and falling under Heading No. 30.03 of the Schedule to the Central Excise Tariff Act, 1985 (5 of 1986), from so much of the duty of excise leviable thereon which is specified in the said Schedule as is in excess of the amount calculated at the rate specified in the corresponding entry in column (3) thereof :

Provided that nothing contained in this notification shall affect the exemption granted under any other notification of the Government of India for the time being in force from the duty of excise specified in the said Schedule in respect of goods referred to in this notification.

TABLE

S. No.	Description of goods	Rate of Duty
(1)	(2)	(3)
1.	All formulations based on the list of bulk drugs (including salts, esters and derivatives, if any) specified in the First Schedule to the Drugs (Prices Control) Order, 1987, as amended from time to time, either individually or in combination with other bulk drugs specified in the said Schedule, excluding formulations based on tetra-cycline or hydrocortisone, for any therapeutic use other than for opthalmological use;	Nil
2.	Single ingredient formulations based on the list of bulk drugs (including salts, esters and derivatives, if any) specified in the Second Schedule to Drugs (Prices Control) Order, 1987, as amended from time to time.	10% ad valorem

Explanation. - For the purposes of this notification, -

(a) the expression "formulations" means medicaments processed out of or containing one or more bulk drugs or drugs with or without the use of any pharmaceutical aids (such as diluent, disintegrating agent, moistening agent, lubricant, buffering agent, stabiliser or preserver) which are therapeutically inert and do not interfere with therapeutic or prophylectic activity of the drugs, for internal or external use for, or in the diagnosis, treatment, mitigation or prevention of disease in human beings or animals, but shall not include any substance to which the provisions of the Drugs and Cosmetics Act, 1940 (23 of 1940) do not apply.

(b) the expression "single ingredient formulations" means medicaments processed out of any single bulk drug or drug, with or without the use of any pharmaceutical aids (such as diluent, disintegrating agent, moistening agent, lubricant, buffering agent, stabiliser or preserver) which are therapeutically inert and do not interfere with the therapeutic or prophylactic activity of the drug, for internal or external use for, or in the diagnosis, treatment, mitigation or prevention of disease in human beings or animals, but shall not include any substance to which the provisions of the Drugs and Cosmetics Act, 1940 (23 of 1940) do not apply.